SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 535 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,313,898 | +9.9% | 199,453 | -0.3% | 0.05% | +14.0% |
| Q2 2023 | $38,498,928 | +113105.5% | 200,036 | +19.1% | 0.04% | +2.4% |
| Q1 2023 | $34,008 | +68.6% | 167,965 | +7.0% | 0.04% | +55.6% |
| Q4 2022 | $20,168 | -99.9% | 156,938 | +6.1% | 0.03% | -10.0% |
| Q3 2022 | $20,232,000 | -20.2% | 147,861 | +3.2% | 0.03% | -18.9% |
| Q2 2022 | $25,348,000 | +38.3% | 143,256 | +12.6% | 0.04% | +54.2% |
| Q1 2022 | $18,330,000 | -10.2% | 127,247 | -3.6% | 0.02% | -4.0% |
| Q4 2021 | $20,410,000 | -5.5% | 132,015 | +3.8% | 0.02% | -13.8% |
| Q3 2021 | $21,597,000 | +6.7% | 127,190 | -0.8% | 0.03% | +7.4% |
| Q2 2021 | $20,239,000 | +8.7% | 128,191 | -4.4% | 0.03% | +8.0% |
| Q1 2021 | $18,614,000 | -27.0% | 134,051 | -7.9% | 0.02% | -28.6% |
| Q4 2020 | $25,504,000 | -12.3% | 145,619 | -2.0% | 0.04% | -23.9% |
| Q3 2020 | $29,067,000 | – | 148,536 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |